XORTX Therapeutics Inc. submitted its 6-K filing to the SEC on October 21, 2025, confirming compliance with annual reporting requirements. The filing does not indicate any significant events or quantitative data.
AI Assistant
XORTX THERAPEUTICS INC
2025
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.